Paratek Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Paratek Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2023.
  • Paratek Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending July 31, 2023 was 57.3M shares, a 4.48% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 57.3M +2.46M +4.48% Jul 31, 2023 10-Q 2023-08-03
Q1 2023 57.3M +2.8M +5.15% Apr 30, 2023 10-Q 2023-05-09
Q3 2022 55.5M +5.36M +10.7% Oct 31, 2022 10-Q 2022-11-03
Q2 2022 54.9M +6.07M +12.4% Jul 31, 2022 10-Q 2022-08-03
Q1 2022 54.5M +7.55M +16.1% Apr 30, 2022 10-Q 2022-05-04
Q3 2021 50.2M +4.55M +9.96% Oct 29, 2021 10-Q 2021-11-08
Q2 2021 48.8M +3.41M +7.51% Jul 30, 2021 10-Q 2021-08-09
Q1 2021 46.9M +3.8M +8.8% Apr 30, 2021 10-Q 2021-05-17
Q3 2020 45.6M +12.4M +37.1% Oct 30, 2020 10-Q 2020-11-05
Q2 2020 45.4M +12.9M +39.5% Jul 31, 2020 10-Q 2020-08-10
Q1 2020 43.1M +10.7M +33.1% Apr 30, 2020 10-Q 2020-05-11
Q3 2019 33.3M +1.15M +3.57% Oct 31, 2019 10-Q 2019-11-12
Q2 2019 32.5M +806K +2.54% Jul 31, 2019 10-Q 2019-08-06
Q1 2019 32.4M +820K +2.6% Apr 30, 2019 10-Q 2019-05-08
Q3 2018 32.1M +4.2M +15% Oct 31, 2018 10-Q 2018-11-06
Q2 2018 31.7M +3.97M +14.3% Jul 31, 2018 10-Q 2018-08-02
Q1 2018 31.6M +4.11M +15% Apr 30, 2018 10-Q 2018-05-09
Q3 2017 27.9M +5.31M +23.5% Oct 31, 2017 10-Q 2017-11-08
Q2 2017 27.8M +5.13M +22.7% Jul 28, 2017 10-Q 2017-08-02
Q1 2017 27.5M +9.75M +54.9% Apr 28, 2017 10-Q 2017-05-04
Q3 2016 22.6M +5.02M +28.5% Oct 31, 2016 10-Q 2016-11-02
Q2 2016 22.6M +5.07M +28.9% Jul 29, 2016 10-Q 2016-08-04
Q1 2016 17.7M +3.32M +23% Apr 29, 2016 10-Q 2016-05-02
Q3 2015 17.6M -1.55M -8.1% Nov 6, 2015 10-Q 2015-11-12
Q2 2015 17.6M -1.6M -8.35% Jul 31, 2015 10-Q 2015-08-11
Q1 2015 14.4M -4.42M -23.5% Feb 28, 2015 10-K/A 2015-04-24
Q3 2014 19.2M +319K +1.69% Oct 24, 2014 10-Q 2014-10-28
Q2 2014 19.2M +401K +2.14% Aug 4, 2014 10-Q 2014-08-06
Q1 2014 18.8M +97.7K +0.52% Mar 12, 2014 10-K 2014-03-14
Q3 2013 18.8M +224K +1.2% Nov 5, 2013 10-Q 2013-11-07
Q2 2013 18.8M +196K +1.06% Aug 6, 2013 10-Q 2013-08-08
Q1 2013 18.7M +4.77M +34.1% Mar 8, 2013 10-K 2013-03-12
Q3 2012 18.6M +5.08M +37.5% Nov 9, 2012 10-Q 2012-11-13
Q2 2012 18.6M +5.04M +37.3% Aug 9, 2012 10-Q 2012-08-13
Q1 2012 14M Mar 26, 2012 10-K 2012-03-30
Q3 2011 13.5M Nov 7, 2011 10-Q 2011-11-10
Q2 2011 13.5M Aug 10, 2011 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.